The rise of antimicrobial resistance (AMR) poses a significant threat to global health. In hospital settings, the judicious use of antimicrobials is crucial to combat this issue. Herein, we discuss strategies for effective antimicrobial stewardship (AMS) and how they contribute towards improved patient care.
AMS is an organized approach to optimize the use of antimicrobials. It aims to improve patient outcomes, reduce AMR, and decrease unnecessary costs associated with overuse and misuse of antimicrobials. AMS programs involve a multidisciplinary team of clinicians, pharmacists, microbiologists, and infection control professionals.
1. Prospective Audit and Feedback: Regular review of antimicrobial prescriptions and feedback to the prescriber can significantly improve prescribing practices.
2. Formulary Restriction and Preauthorization: Restricting the use of certain antimicrobials can limit their overuse and misuse.
3. Education and Training: Regular training of healthcare professionals on the principles of AMS can enhance their competency and adherence to guidelines.
4. Antimicrobial Cycling and De-escalation: Regular rotation of antimicrobials and de-escalation from broad to narrow-spectrum agents can help prevent the emergence of resistance.
5. Use of Rapid Diagnostic Tests: These tests can help in early identification of pathogens and appropriate antimicrobial selection.
Effective AMS strategies lead to better patient outcomes by reducing the incidence of drug-resistant infections and adverse drug events. They also ensure that effective antimicrobial agents remain available for future use. Patient safety is enhanced, and hospital stay and associated costs are minimized.
Implementing robust AMS strategies in hospital settings is a critical step towards better patient care. It requires a collaborative effort from all healthcare professionals to ensure the judicious use of antimicrobials and to combat the growing threat of AMR.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation